Skip to Content

Chalice Brands Ltd CHALF

Morningstar Rating
$0.00 0.00 (99.50%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

CHALF is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$7.98
Uncertainty
Extreme
1-Star Price
$6.29
5-Star Price
$1.46
Economic Moat
Jccwx
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if CHALF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.41
Bid/Ask
$0.06 / $0.07
Market Cap
$65.33
Volume/Avg
209 / 4,265

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Chalice Brands Ltd is a premier consumer-driven cannabis company specializing in production, processing, wholesale, distribution and retail, with twelve dispensaries owned and four dispensaries under management in Oregon. The company is committed to developing a dynamic portfolio built around the recognized brands of Chalice Farms, with a focus on health and wellness. It operates nationally through Fifth & Root and has operations in Oregon and California.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
313

Valuation

Metric
CHALF
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
CHALF

Financial Strength

Metric
CHALF
Quick Ratio
0.20
Current Ratio
0.61
Interest Coverage
−1.19
Quick Ratio
CHALF

Profitability

Metric
CHALF
Return on Assets (Normalized)
−15.40%
Return on Equity (Normalized)
−89.68%
Return on Invested Capital (Normalized)
−18.83%
Return on Assets
CHALF
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class ANhgtqlmdNlzr$79.4 Bil
MKKGY
Merck KGaA ADRNtmtcqbcvThwww$79.0 Bil
HLN
Haleon PLC ADRCykbtrjYjphd$38.5 Bil
VTRS
Viatris IncCvkndtzxTkvjt$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRJslblbnwRlr$11.6 Bil
CTLT
Catalent IncYhyyjclFyvmmp$10.0 Bil
CURLF
Curaleaf Holdings IncKybfmhwjkWfy$4.2 Bil
PRGO
Perrigo Co PLCLkjcxqkkmVnfh$4.0 Bil
PBH
Prestige Consumer Healthcare IncDpvlbdspbKyfbzt$3.2 Bil
GTBIF
Green Thumb Industries IncBjpgtsqxvYsl$3.1 Bil

Sponsor Center